Test filters | DNDi

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

News

12 Mar 2026

2025 R&D programmes in review: Chagas disease

News

12 Mar 2026

2025 R&D programmes in review: Parasitic worms

News

12 Mar 2026

2025 R&D programmes in review: Mycetoma

News

12 Mar 2026

2025 R&D programmes in review: Dengue

News

12 Mar 2026

2025 R&D programmes in review: HIV

News

12 Mar 2026

2025 R&D programmes in review: Hepatitis C

News

12 Mar 2026

2025 R&D programmes in review: Pandemic preparedness

In the media

11 Mar 2026

Tres pastillas para eliminar la enfermedad del sueño en un contexto de recortes globales en ayuda al desarrollo

El País

In the media

10 Mar 2026

Entretien avec Dr Hélène Mahenzi à propos d’un nouveau médicament développé contre la maladie du sommeil

RFI Priorité Santé

In the media

9 Mar 2026

Falta de medicamentos, centros médicos destruidos y recortes: cómo la guerra en Sudán ha golpeado a las enfermedades más olvidadas

El País

Scientific articles

27 Feb 2026

Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review

PLOS Neglected Tropical Diseases

Scientific articles

18 Feb 2026

An MRC-5 cell based high-throughput, high-content imaging assay to identify hits against Trypanosoma cruzi intracellular parasites

SLAS Discovery

Press releases

4 Mar 2026

Pandemic preparedness: Novo Nordisk Foundation renews its support to DNDi and THSTI to continue the development of broad-spectrum antivirals

In the media

3 Mar 2026

Traitement à dose unique approuvé pour la maladie du sommeil

Nature Africa

In the media

3 Mar 2026

Single-dose treatment approved for sleeping sickness

Nature Africa

In the media

2 Mar 2026

Europa da el visto bueno a una terapia más sencilla contra la enfermedad del sueño

La Razon

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

2025 R&D programmes in review: Chagas disease

2025 R&D programmes in review: Parasitic worms

2025 R&D programmes in review: Mycetoma

2025 R&D programmes in review: Dengue

2025 R&D programmes in review: HIV

2025 R&D programmes in review: Hepatitis C

2025 R&D programmes in review: Pandemic preparedness

Tres pastillas para eliminar la enfermedad del sueño en un contexto de recortes globales en ayuda al desarrollo

Entretien avec Dr Hélène Mahenzi à propos d’un nouveau médicament développé contre la maladie du sommeil

Falta de medicamentos, centros médicos destruidos y recortes: cómo la guerra en Sudán ha golpeado a las enfermedades más olvidadas

Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review

An MRC-5 cell based high-throughput, high-content imaging assay to identify hits against Trypanosoma cruzi intracellular parasites

Pandemic preparedness: Novo Nordisk Foundation renews its support to DNDi and THSTI to continue the development of broad-spectrum antivirals

Traitement à dose unique approuvé pour la maladie du sommeil

Single-dose treatment approved for sleeping sickness

Europa da el visto bueno a una terapia más sencilla contra la enfermedad del sueño

Learn more

Get in touch

Support us

Work with us